Swedish Porphyria Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.

The global market for Swedish Porphyria Therapeutics was estimated to be worth US$ 49 million in 2023 and is forecast to a readjusted size of US$ 56 million by 2030 with a CAGR of 1.8% during the forecast period 2024-2030

Swedish Porphyria Therapeutics Market Size

M= millions and B=billions

Panhematin (hemin) is a medication used to treat acute porphyria, a rare genetic disorder that affects heme production. Its effectiveness in managing acute porphyria attacks and reducing symptoms has driven market growth. The rarity of the condition and limited treatment options contribute to its niche status. However, challenges include the need for careful monitoring and potential side effects. The market competition is relatively small, as Panhematin remains a specialized therapy. 
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swedish Porphyria Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Swedish Porphyria Therapeutics by region & country, by Type, and by Application.

The Swedish Porphyria Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swedish Porphyria Therapeutics.

Market Segmentation

• Report Metric

• Details

• Report Title

• Swedish Porphyria Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Forecasted Market Size in 2030

• US$ 56 million

• CAGR(2024-2030)

• 1.8%

• Market Size Available for Years

• 2019-2030

• Global Swedish Porphyria Therapeutics Companies Covered

• Recordati Rare Diseases

• Global Swedish Porphyria Therapeutics Market, by Region

• North America (U.S., Canada, Mexico)

  Europe (Germany, France, UK, Italy, etc.)

  Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

  South America (Brazil, etc.)

  Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

• Global Swedish Porphyria Therapeutics Market, Segment by Type

• 350mg

  313mg

• Global Swedish Porphyria Therapeutics Market, Segment by Application

• Hospital

  Pharmacy

• Forecast Units

• USD million in value

• Report Coverage

• Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Swedish Porphyria Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Swedish Porphyria Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Swedish Porphyria Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Swedish Porphyria Therapeutics Product Introduction
    1.2 Global Swedish Porphyria Therapeutics Market Size Forecast
    1.3 Swedish Porphyria Therapeutics Market Trends & Drivers
        1.3.1 Swedish Porphyria Therapeutics Industry Trends
        1.3.2 Swedish Porphyria Therapeutics Market Drivers & Opportunity
        1.3.3 Swedish Porphyria Therapeutics Market Challenges
        1.3.4 Swedish Porphyria Therapeutics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Swedish Porphyria Therapeutics Players Revenue Ranking (2023)
    2.2 Global Swedish Porphyria Therapeutics Revenue by Company (2019-2024)
    2.3 Key Companies Swedish Porphyria Therapeutics Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Swedish Porphyria Therapeutics Product Offered
    2.5 Key Companies Time to Begin Mass Production of Swedish Porphyria Therapeutics
    2.6 Swedish Porphyria Therapeutics Market Competitive Analysis
        2.6.1 Swedish Porphyria Therapeutics Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Swedish Porphyria Therapeutics Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swedish Porphyria Therapeutics as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 350mg
        3.1.2 313mg
    3.2 Global Swedish Porphyria Therapeutics Sales Value by Type
        3.2.1 Global Swedish Porphyria Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Swedish Porphyria Therapeutics Sales Value, by Type (2019-2030)
        3.2.3 Global Swedish Porphyria Therapeutics Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Pharmacy
    4.2 Global Swedish Porphyria Therapeutics Sales Value by Application
        4.2.1 Global Swedish Porphyria Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Swedish Porphyria Therapeutics Sales Value, by Application (2019-2030)
        4.2.3 Global Swedish Porphyria Therapeutics Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Swedish Porphyria Therapeutics Sales Value by Region
        5.1.1 Global Swedish Porphyria Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Swedish Porphyria Therapeutics Sales Value by Region (2019-2024)
        5.1.3 Global Swedish Porphyria Therapeutics Sales Value by Region (2025-2030)
        5.1.4 Global Swedish Porphyria Therapeutics Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Swedish Porphyria Therapeutics Sales Value, 2019-2030
        5.2.2 North America Swedish Porphyria Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Swedish Porphyria Therapeutics Sales Value, 2019-2030
        5.3.2 Europe Swedish Porphyria Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Swedish Porphyria Therapeutics Sales Value, 2019-2030
        5.4.2 Asia Pacific Swedish Porphyria Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Swedish Porphyria Therapeutics Sales Value, 2019-2030
        5.5.2 South America Swedish Porphyria Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Swedish Porphyria Therapeutics Sales Value, 2019-2030
        5.6.2 Middle East & Africa Swedish Porphyria Therapeutics Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Swedish Porphyria Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Swedish Porphyria Therapeutics Sales Value
    6.3 United States
        6.3.1 United States Swedish Porphyria Therapeutics Sales Value, 2019-2030
        6.3.2 United States Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Swedish Porphyria Therapeutics Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Swedish Porphyria Therapeutics Sales Value, 2019-2030
        6.4.2 Europe Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Swedish Porphyria Therapeutics Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Swedish Porphyria Therapeutics Sales Value, 2019-2030
        6.5.2 China Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Swedish Porphyria Therapeutics Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Swedish Porphyria Therapeutics Sales Value, 2019-2030
        6.6.2 Japan Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Swedish Porphyria Therapeutics Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Swedish Porphyria Therapeutics Sales Value, 2019-2030
        6.7.2 South Korea Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Swedish Porphyria Therapeutics Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Swedish Porphyria Therapeutics Sales Value, 2019-2030
        6.8.2 Southeast Asia Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Swedish Porphyria Therapeutics Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Swedish Porphyria Therapeutics Sales Value, 2019-2030
        6.9.2 India Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Swedish Porphyria Therapeutics Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Recordati Rare Diseases
        7.1.1 Recordati Rare Diseases Profile
        7.1.2 Recordati Rare Diseases Main Business
        7.1.3 Recordati Rare Diseases Swedish Porphyria Therapeutics Products, Services and Solutions
        7.1.4 Recordati Rare Diseases Swedish Porphyria Therapeutics Revenue (US$ Million) & (2019-2024)
        7.1.5 Recordati Rare Diseases Recent Developments

 8 Industry Chain Analysis
    8.1 Swedish Porphyria Therapeutics Industrial Chain
    8.2 Swedish Porphyria Therapeutics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Swedish Porphyria Therapeutics Sales Model
        8.5.2 Sales Channel
        8.5.3 Swedish Porphyria Therapeutics Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Swedish Porphyria Therapeutics Market Trends
    Table 2. Swedish Porphyria Therapeutics Market Drivers & Opportunity
    Table 3. Swedish Porphyria Therapeutics Market Challenges
    Table 4. Swedish Porphyria Therapeutics Market Restraints
    Table 5. Global Swedish Porphyria Therapeutics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Swedish Porphyria Therapeutics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Swedish Porphyria Therapeutics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Swedish Porphyria Therapeutics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Swedish Porphyria Therapeutics
    Table 10. Global Swedish Porphyria Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swedish Porphyria Therapeutics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Swedish Porphyria Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Swedish Porphyria Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Swedish Porphyria Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Swedish Porphyria Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Swedish Porphyria Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Swedish Porphyria Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Swedish Porphyria Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Swedish Porphyria Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Swedish Porphyria Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Swedish Porphyria Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Swedish Porphyria Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Swedish Porphyria Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Swedish Porphyria Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Swedish Porphyria Therapeutics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Swedish Porphyria Therapeutics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Swedish Porphyria Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Swedish Porphyria Therapeutics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Swedish Porphyria Therapeutics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Recordati Rare Diseases Basic Information List
    Table 32. Recordati Rare Diseases Description and Business Overview
    Table 33. Recordati Rare Diseases Swedish Porphyria Therapeutics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Swedish Porphyria Therapeutics Business of Recordati Rare Diseases (2019-2024)
    Table 35. Recordati Rare Diseases Recent Developments
    Table 36. Key Raw Materials Lists
    Table 37. Raw Materials Key Suppliers Lists
    Table 38. Swedish Porphyria Therapeutics Downstream Customers
    Table 39. Swedish Porphyria Therapeutics Distributors List
    Table 40. Research Programs/Design for This Report
    Table 41. Key Data Information from Secondary Sources
    Table 42. Key Data Information from Primary Sources
    Table 43. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Swedish Porphyria Therapeutics Product Picture
    Figure 2. Global Swedish Porphyria Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Swedish Porphyria Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Swedish Porphyria Therapeutics Report Years Considered
    Figure 5. Global Swedish Porphyria Therapeutics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Swedish Porphyria Therapeutics Revenue in 2023
    Figure 7. Swedish Porphyria Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. 350mg Picture
    Figure 9. 313mg Picture
    Figure 10. Global Swedish Porphyria Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Swedish Porphyria Therapeutics Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Pharmacy
    Figure 14. Global Swedish Porphyria Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Swedish Porphyria Therapeutics Sales Value Market Share by Application, 2023 & 2030
    Figure 16. North America Swedish Porphyria Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 17. North America Swedish Porphyria Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 18. Europe Swedish Porphyria Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 19. Europe Swedish Porphyria Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 20. Asia Pacific Swedish Porphyria Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 21. Asia Pacific Swedish Porphyria Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 22. South America Swedish Porphyria Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 23. South America Swedish Porphyria Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 24. Middle East & Africa Swedish Porphyria Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 25. Middle East & Africa Swedish Porphyria Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 26. Key Countries/Regions Swedish Porphyria Therapeutics Sales Value (%), (2019-2030)
    Figure 27. United States Swedish Porphyria Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 28. United States Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 29. United States Swedish Porphyria Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 30. Europe Swedish Porphyria Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 31. Europe Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 32. Europe Swedish Porphyria Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 33. China Swedish Porphyria Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 34. China Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 35. China Swedish Porphyria Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 36. Japan Swedish Porphyria Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Japan Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 38. Japan Swedish Porphyria Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 39. South Korea Swedish Porphyria Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 40. South Korea Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 41. South Korea Swedish Porphyria Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 42. Southeast Asia Swedish Porphyria Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 44. Southeast Asia Swedish Porphyria Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 45. India Swedish Porphyria Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 46. India Swedish Porphyria Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 47. India Swedish Porphyria Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 48. Swedish Porphyria Therapeutics Industrial Chain
    Figure 49. Swedish Porphyria Therapeutics Manufacturing Cost Structure
    Figure 50. Channels of Distribution (Direct Sales, and Distribution)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation

Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.

The global market for Swedish Porphyria Therapeutics was estimated to be worth US$ 49 million in 2023 and is forecast to a readjusted size of US$ 56 million by 2030 with a CAGR of 1.8% during the forecast period 2024-2030

Panhematin (hemin) is a medication used to treat acute porphyria, a rare genetic disorder that affects heme production. Its effectiveness in managing acute porphyria attacks and reducing symptoms has driven market growth. The rarity of the condition and limited treatment options contribute to its niche status. However, challenges include the need for careful monitoring and potential side effects. The market competition is relatively small, as Panhematin remains a specialized therapy. 
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swedish Porphyria Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Swedish Porphyria Therapeutics by region & country, by Type, and by Application.

The Swedish Porphyria Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swedish Porphyria Therapeutics.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Swedish Porphyria Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Swedish Porphyria Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Swedish Porphyria Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.